Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent.

Catheter Cardiovasc Interv · 2022 · PMC9542312 · PMID 35384254

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Differences in TLF rates after treatment with the DTS versus SES in the insulin‐treated DM patients did not reach statistical significance (9 [9.5%] vs. 7 [7.7%], incidence rate ratio 1.25, 95% confidence interval 0.46–3.40).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.